SwedenUterusKidney TransplantationTransplantsGraft RejectionGraft SurvivalImmunosuppressive AgentsHeart TransplantationTransplantation, HomologousTransplantationTissue DonorsLung TransplantationPregnancyTime FactorsUterine ContractionTissue and Organ ProcurementEmbryo ImplantationBone Marrow TransplantationRetrospective StudiesPregnancy, AnimalTreatment OutcomeMyometriumCyclosporineTacrolimusPostoperative ComplicationsLiving DonorsRisk FactorsWaiting ListsImmunosuppressionCervix UteriHematopoietic Stem Cell TransplantationEndometriumIncidenceUterine DiseasesRegistriesFetal Tissue TransplantationCytomegalovirus InfectionsEstradiolFollow-Up StudiesMycophenolic AcidDeciduaUterine NeoplasmsProgesteroneHistocompatibility TestingOvariectomyCadaverTransplantation ImmunologyKidney Failure, ChronicImmunocompromised HostLiver FailurePseudopregnancyGraft vs Host DiseaseCohort StudiesProspective StudiesHeart-Lung TransplantationTransplantation, AutologousScandinaviaBrain Tissue TransplantationEuropeSurvival RateEstrusAge FactorsBronchiolitis ObliteransSurvival AnalysisTransplantation, HeterotopicHistocompatibilityRecurrenceBiopsyFallopian TubesTransplantation ToleranceOpportunistic InfectionsCytomegalovirusTransplantation ConditioningKidneyGenitalia, FemaleHysterectomyBK VirusRisk AssessmentEstrous CycleHLA AntigensOvaryGanciclovirVaginaOxytocinAntilymphocyte SerumIsoantibodiesRNA, MessengerImmunohistochemistryPolyomavirus InfectionsPrevalenceCase-Control StudiesPrognosisPlacentaLymphoproliferative DisordersEnd Stage Liver DiseaseLabor, ObstetricEstrogensAcute DiseaseTransplantation, IsogeneicPolymerase Chain Reaction